Your session is about to expire
← Back to Search
Consult followed by Engage Model for Hearing Loss (HearCARE Trial)
N/A
Waitlist Available
Led By Catherine Palmer, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (enrollment), at 5, 10, 15, 20 and 25 months
Awards & highlights
HearCARE Trial Summary
This trial proposes to compare the effectiveness of the two models of care on (a) communication ability, (b) health-related quality of life, and (c) hearing aid use.
Eligible Conditions
- Age-Related Hearing Loss
HearCARE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (enrollment), at 5, 10, 15, 20 and 25 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (enrollment), at 5, 10, 15, 20 and 25 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Hearing-Specific Health-Related Quality of Life
Satisfaction with Social Participation
Secondary outcome measures
Family Burden
Staff Satisfaction
HearCARE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Consult ModelExperimental Treatment1 Intervention
The Consult Model (i.e., usual care) is an acute care strategy, relying on a monthly Audiologist visit to the facility.
Group II: HearCARE (Consult+Engage)Active Control2 Interventions
Residents will be exposed to the Consult Model and the Engage Model.
Find a Location
Who is running the clinical trial?
University of PittsburghLead Sponsor
1,719 Previous Clinical Trials
16,341,659 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
549 Previous Clinical Trials
29,995,866 Total Patients Enrolled
Catherine Palmer, PhD5.01 ReviewsPrincipal Investigator - University of Pittsburgh
University of Pittsburgh
5Patient Review
Dr. Palmer is extremely knowledgeable and always takes the time to explain things in detail. She's also very supportive and encouraging, which makes me feel confident that I'm in good hands. I'm fortunate to have her as my audiologist!
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Consult Model
- Group 2: HearCARE (Consult+Engage)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there a period for new enrolment within this experiment?
"The information hosted on clinicaltrials.gov reveals that this experiment is currently seeking subjects, with the initial post date being June 1st 2021 and last updated April 29th 2022."
Answered by AI
What is the current size of the cohort involved in this clinical trial?
"Affirmative. Records on clinicaltrials.gov verifies that this experiment, which was published initially in June 2021, is presently enlisting volunteers. Approximately 520 patients need to be recruited from 1 trial centre."
Answered by AI
Share this study with friends
Copy Link
Messenger